Kennedy Capital Management’s Castle Biosciences CSTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.1M Sell
339,263
-9,108
-3% -$275K 0.23% 153
2026
Q2
$8.31M Buy
+348,371
New +$7.76M 0.15% 238

Other funds holding CSTL

Kennedy Capital Management's CSTL Position: Q3 2026 in Review

Kennedy Capital Management reduced its Castle Biosciences (CSTL) stake by 2.6% in Q3 2026, selling an estimated $275K and leaving 339,263 shares worth $12.1M. The position accounts for 0.23% of the portfolio, ranked #153.

Kennedy Capital Management first reported a position in CSTL in Q2 2026 and has held it in 2 quarters since. 201 funds tracked by Wall St. Rank hold CSTL as of Q3 2026.

  • Kennedy Capital Management held 339,263 shares of Castle Biosciences worth $12.1M as of Q3 2026.
  • Kennedy Capital Management sold 9,108 Castle Biosciences shares in Q3 2026, an estimated $275K.
  • Castle Biosciences made up 0.23% of Kennedy Capital Management's portfolio in Q3 2026, its #153 holding.
  • Kennedy Capital Management first reported a position in Castle Biosciences in Q2 2026 and has held it in 2 quarters since.
  • 201 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2026.

Based on Kennedy Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.